Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001424411-08-000054
Filing Date
2008-12-15
Accepted
2008-12-15 20:41:45
Documents
1
Period of Report
2008-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7617
  Complete submission text file 0001424411-08-000054.txt   9650
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO RIVER GROUP HOLDINGS, LLC. 689 FIFTH AVENUE NEW YORK NY 10022
Business Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019 212-871-7900
TANEN DAVID M (Reporting) CIK: 0001170542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 081251038